Patents by Inventor Batchu Chandrasekhar

Batchu Chandrasekhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7951937
    Abstract: A process of azeotropic removal of dimethylformamide, abbreviated as DMF, from a process stream containing DMF requiring its removal, is described wherein the said Process Stream being obtained in a process for preparation of 4,1?,6? trichlorogalactosucrose, abbreviated as TGS, or TGS-6-ester including TGS-6-acetate or TGS-6-benzoate, comprising steps of (a) evaporation of the said process stream under reduced pressure to a concentrate to effect removal of a part of DMF azeotropically, (b) diluting the concentrate obtained at the end of step (a.) of this claim with water, preferably to about 5 to 10 times the volume of the said concentrate, and (c) repeating the cycles of evaporation under reduced pressure and dilution with water for more number of times until content of DMF in the concentrated mass is reduced to 0.5% or less of the concentrate.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: May 31, 2011
    Assignee: V.B. Medicare Private Limited
    Inventors: Rakesh Ratnam, Sundeep Aurora, Batchu Chandrasekhar
  • Publication number: 20100056773
    Abstract: A process is described in which decolorization of solutions or reaction mixtures containing trichlorogalactosucrose or 6-acetyl trichlorogalactosucrose is achieved described by bubbling ozone. The method can be used at various stages in the process of production and with or without a combination with other adsorbents for colour removal.
    Type: Application
    Filed: January 2, 2008
    Publication date: March 4, 2010
    Applicant: V.B. Medicare PVT. Ltd.
    Inventors: Batchu Chandrasekhar, Andanagouda Sharanappagouda Patil, Rakesh Ratnam, Sundeep Aurora
  • Publication number: 20090281146
    Abstract: The present invention relates to a method of preparing N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide and pharmaceutically acceptable salts thereof, such as its sodium salt, and novel intermediate compounds useful in the synthesis of the aforementioned compound.
    Type: Application
    Filed: July 17, 2009
    Publication date: November 12, 2009
    Applicant: Glenmark Pharmaceuticals, S.A.
    Inventors: Balasubramanian Gopalan, Laxmikant A. Gharat, Batchu Chandrasekhar, Bijukumar Gopinathan Pillai
  • Patent number: 7563900
    Abstract: The present invention relates to a method of preparing N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide and pharmaceutically acceptable salts thereof, such as its sodium salt, and novel intermediate compounds useful in the synthesis of the aforementioned compound.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: July 21, 2009
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Balasubramanian Gopalan, Laxmikant A. Gharat, Batchu Chandrasekhar, Bijukumar G. Pillai
  • Publication number: 20090118493
    Abstract: A process of azeotropic removal of dimethylformamide, abbreviated as DMF, from a process stream containing DMF requiring its removal, is described wherein the said Process Stream being obtained in a process for preparation of 4,1?,6? trichlorogalactosucrose, abbreviated as TGS, or TGS-6-ester including TGS-6-acetate or TGS-6-benzoate, comprising steps of (a) evaporation of the said process stream under reduced pressure to a concentrate to effect removal of a part of DMF azeotropically, (b) diluting the concentrate obtained at the end of step (a.) of this claim with water, preferably to about 5 to 10 times the volume of the said concentrate, and (c) repeating the cycles of evaporation under reduced pressure and dilution with water for more number of times until content of DMF in the concentrated mass is reduced to 0.5% or less of the concentrate.
    Type: Application
    Filed: August 29, 2006
    Publication date: May 7, 2009
    Applicant: PHARMED MEDICARE PVT. LTD.
    Inventors: Rakesh Ratnam, Sundeep Aurora, Batchu Chandrasekhar
  • Patent number: 7414143
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a ?-chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: August 19, 2008
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Vishvas Dattatraya Patil, Changdev Namdev Raut, Shekhar Bhaskar Bhirud, Batchu Chandrasekhar
  • Patent number: 7312329
    Abstract: An improved process for the preparation of pyrimidine derivatives is provided comprising reacting a Wittig reagent of the general formula wherein R is an alkyl of from 1 to 10 carbon atoms, aryl or arylalkyl, R1 is a substituted or unsubstituted hydrocarbon group, R2 and R3 are the same or different and are hydrogen or a substituted or unsubstituted hydrocarbon group; Z is sulfur, oxygen, sulfonyl, or imino which may be substituted by formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, amino substituted by sulfonyl or alkylsulfonyl, and sulfonyl substituted by alkyl, amino or alkylamino and X is a halogen; with an aldehyde of the general formula wherein R4 is hydrogen, a lower alkyl or a cation capable of forming a non-toxic pharmaceutically acceptable salt and each R5 are the same or different and are hydrogen or a hydrolyzable protecting group, or each R5, together with the oxygen atom to which each is bonded, form a hydrolyzable cyclic protecting group, or each R5 is bonded to the
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: December 25, 2007
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Narendra Joshi, Shekhar Bhaskar Bhirud, Batchu Chandrasekhar, K. Eswara Rao, Subhash Damle
  • Publication number: 20060135779
    Abstract: The present invention relates to a method of preparing N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide and pharmaceutically acceptable salts thereof, such as its sodium salt, and novel intermediate compounds useful in the synthesis of the aforementioned compound.
    Type: Application
    Filed: October 13, 2005
    Publication date: June 22, 2006
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Balasubramanian Gopalan, Laxmikant Gharat, Batchu Chandrasekhar, Bijukumar Pillai
  • Publication number: 20060106233
    Abstract: A process for the preparation of a disubstituted acetylene bearing heteroaromatic and heterobicyclic groups of formula I is provided wherein X is S, O, or NR1 wherein R1 is hydrogen or a C1-C6 straight or branched alkyl group; R is hydrogen or a C1-C6 straight or branched alkyl group; A is a substituted or unsubstituted pyridinyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl group; n is 0-4; and B is H, —COOH, —CH2OH, —CHO or a C1-C6 alkyl acetal derivative, —COR2 or a C1-C6 alkyl ketal derivative where R2 is —(CH2)mCH3 where m is 0-4 or COOR3 wherein R3 is a straight or branched C1-C30 alkyl group, a substituted or unsubstituted C6-C30 aromatic group, a substituted or unsubstituted C3-C30 cycloalkyl, a substituted or unsubstituted C3-C30 cycloalkylalkyl, a substituted or unsubstituted C3-C30 cycloalkenyl, a substituted or unsubstituted C5-C30 aryl, a substituted or unsubstituted C5-C30 arylalkyl, a substituted or unsubstituted C5-C30 heteroaryl, a substituted or unsubstituted C3-C30 heterocycli
    Type: Application
    Filed: June 17, 2005
    Publication date: May 18, 2006
    Applicant: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Kumar, Shekhar Bhirud, Batchu Chandrasekhar, Changdev Raut
  • Publication number: 20060084814
    Abstract: The present invention provides an improved process for the preparation of zonisamide or a derivative thereof comprising (a) reacting 1,2-benzisoxazole-3-methane-sulfonic acid with a halogenating agent in a first organic solvent to provide benzisoxazole methane sulfonyl halide; and, (b) reacting benzisoxazole methane sulfonyl halide with an amine in a second organic solvent to form zonisamide or a derivative thereof.
    Type: Application
    Filed: May 20, 2005
    Publication date: April 20, 2006
    Inventors: Bobba Siva Kumar, Shekhar Bhirud, Batchu Chandrasekhar, Sanjay Kale
  • Publication number: 20050282878
    Abstract: The present invention relates to processes for the purification of crude fluconazole including at least a first leaching, a second leaching, and an acid/base treatment and to highly purified fluconazole produced from the processes.
    Type: Application
    Filed: April 12, 2005
    Publication date: December 22, 2005
    Inventors: Batchu Chandrasekhar, Ramasubramanian Sridharan, Biju Kumar Gopinathen Pillai, Shekhar Bhirud
  • Patent number: 6963002
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a ?-chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound in
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: November 8, 2005
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Vishvas Dattatraya Patil, Changdev Namdev Raut, Shekhar Bhaskar Bhirud, Batchu Chandrasekhar
  • Publication number: 20050240029
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound inte
    Type: Application
    Filed: June 22, 2005
    Publication date: October 27, 2005
    Applicant: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Kumar, Vishvas Patil, Changdev Raut, Shekhar Bhirud, Batchu Chandrasekhar
  • Publication number: 20050171165
    Abstract: A process for preparing a novel intermediate in the preparation of perindopril is provided.
    Type: Application
    Filed: November 10, 2004
    Publication date: August 4, 2005
    Inventors: Shekhar Bhirud, Suhail Ahmed, Batchu Chandrasekhar, Vandanapu Loka Purushotham
  • Publication number: 20050124639
    Abstract: An improved process for the preparation of pyrimidine derivatives is provided comprising reacting a Wittig reagent of the general formula wherein R is an alkyl of from 1 to 10 carbon atoms, aryl or arylalkyl, R1 is a substituted or unsubstituted hydrocarbon group, R2 and R3 are the same or different and are hydrogen or a substituted or unsubstituted hydrocarbon group; Z is sulfur, oxygen, sulfonyl, or imino which may be substituted by formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, amino substituted by sulfonyl or alkylsulfonyl, and sulfonyl substituted by alkyl, amino or alkylamino and X is a halogen; with an aldehyde of the general formula wherein R4 is hydrogen, a lower alkyl or a cation capable of forming a non-toxic pharmaceutically acceptable salt and each R5 are the same or different and are hydrogen or a hydrolyzable protecting group, or each R5, together with the oxygen atom to which each is bonded, form a hydrolyzable cyclic protecting group, or each R5 is bonded to the
    Type: Application
    Filed: December 3, 2004
    Publication date: June 9, 2005
    Inventors: Narendra Joshi, Shekhar Bhirud, Batchu Chandrasekhar, K. Rao, Subhash Damle
  • Publication number: 20050004373
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a ?-chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound in
    Type: Application
    Filed: July 2, 2004
    Publication date: January 6, 2005
    Inventors: Bobba Kumar, Vishvas Patil, Changdev Raut, Shekhar Bhirud, Batchu Chandrasekhar